New Novotech Report Finds 1,000 HIV Clinical Trials Globally
28 déc. 2023 21h49 HE
|
Novotech
Novotech today released the latest 2023 global clinical trial landscape report on HIV, a condition now affecting more than 39 million people.
Novotech Identifies Decentralized Clinical Trials Potential and Challenges for Accelerating Global Biotech Clinical Trials in 2024
26 nov. 2023 17h54 HE
|
Novotech
Novotech will be presenting at the Clinical Research Governance (CRGo) World Conference & International Clinical Trial Center Network (ICN) Symposium 2023
Novotech Opens ChinaTrials 15 Conference with Workshop on how Biotechs can Accelerate Global Trials
07 nov. 2023 02h24 HE
|
Novotech
Novotech CRO opens the ChinaTrials 15 conference in Shanghai, China on accelerating drug development.
Novotech Publishes Whitepaper on Infectious Diseases Clinical Trials, Revealing Over 7,000 Trials Launched Worldwide
06 nov. 2023 19h10 HE
|
Novotech
Novotech CRO today published the latest 2023 global clinical trial environment whitepaper focused on infectious diseases.
Novotech Releases In-Depth 2023 Global Clinical Trial Landscape Reports on Hemophilia and Primary Biliary Cholangitis
02 nov. 2023 03h48 HE
|
Novotech
Novotech today published the latest 2023 global clinical trial landscape reports on Primary Biliary Cholangitis (PBC) and Hemophilia.
Novotech Announces Key Leadership Appointments: Rick Farris, North America Managing Director and Dr. David Ng, Global Vice President of Biometrics and Data
12 oct. 2023 23h38 HE
|
Novotech
Novotech announces significant senior executive hires to further expand services for Novotech’s global biotech clients.
Dr. Yooni Kim, Vice President of Clinical Services at Novotech, Delivers Keynote Address at Veeva Korea Summit
12 oct. 2023 05h03 HE
|
Novotech
Dr. Yooni Kim, Vice President of Clinical Services at Novotech, served as a keynote speaker at the Veeva Korea Summit this week in Seoul, Korea
Novotech Secures Consecutive Frost & Sullivan CRO Company of the Year Award
10 oct. 2023 03h59 HE
|
Novotech
Novotech has been selected as the CRO Company of the Year 2023 by growth advisory and opportunity analytics firm Frost & Sullivan.
Novotech Appoints Dr. Judith Ng-Cashin as Chief Medical Officer to Drive Global Medical Services
03 oct. 2023 11h54 HE
|
Novotech
Novotech, the leading Asia Pacific-centred biotech CRO with global execution capabilities, announced today the appointment of Dr. Judith Ng-Cashin as CMO.
Clinical Trials in China: Unlocking the Potential of Advanced Therapies Presented by Novotech and Endpoints News
11 sept. 2023 16h32 HE
|
Novotech
BOSTON, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, announced today an expert panel webinar on Clinical Trials in...